1Santana AN, Kairalla BA, Carvalho CR, et al. Potential role of statin use in idiopathic pulmonary fibrosis[J]. Am J Respir Crit Care Med, 2008, 177:1048 -1048.
3Figueira de Mello C,C, Ribeiro Carvalho CR, Adib Kairalla B, et al. Small airway remodeling in idiopathic interstitial pneumonias: a pathological study [J]. Respiration, 2010, 79:322 - 332.
二级参考文献10
1Hadden HZ, Henke CA. Induction of lung fibroblast apoptosis by soluble fibronection peptides [ J 1. Am J Eespir Crit Care Meal, 2000, 162:1553-1560.
2Keina LW, Edith MS, Gregory SS, et al. Simvastatin Inhibits Growth Factor Expression and modulates profibrogenic markers in lung fibroblasts [J]. Am J Respir Cell Mol Biol, 2005, 32: 290- 300.
3Szapiel SV, Elson NA, Fulmer JD, et al. BLM-induced interstitial pulmonary disease in the nude, athymic mouse [J]. Am Rev Respir Dis, 1979, 120 (4) : 893 -899.
4Fulmer JD, Bienkowski RS, Cowan MJ, et al. Collagen concentration and rates of synthesis in idiopathic pulmonary fibrosis [J]. Am Rev Respir Dis, 1980, 122 (2) : 289 - 301.
5Chade AR, Zbu XY, Grande JP, et al. Simvastatin abates development of renal fibrosis in experimental renovascular disease [J]. J Hypertens, 2008, 26 (8) : 1553 - 1555.
6Koepke ML, Weber M, Schulze-Lohoff E, et al. Nephro protective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome [J].Nephrol Dial Transplant, 2007, 22 (4) : 1062 - 1069.
7Porter KE, Turner NA, O'Regan D J, et al. Simvastafin reduces human atrial myofibroblast proliferation independently of cholesterol lowering via inhibition of RhoA [J].Cardiovase Res, 2004, 61 (4) : 745 -755.
8Kelynack KJ, Hewitson TD, Martic M, et al. Lovastatin downregulates renal myofibroblast function in vitro [J]. Nephron, 2002, 91 (4): 701 -707.
9Moore BB, Hogaboam CM. Murine models of pulmonary fibrosis [J]. Am J Physiol Lung Cell Mol Pbysiol, 2008, 294 (2) : L152 - 160.
10Moeller A, Ask K, Warburton D, et al. The BLM animal model : a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?[J].Int J Biochem Cell Biol, 2008, 40 (3) : 362 - 382.
4Hackam DG,Mamdani M,Li P,et al. Statins and sepsis inpa-tients with cardiovascular disease: a population - basedcohort a*nalysis[ J]. Lancet,2006,367(9508) :413 -418.
5Wahner A D,Bronstein J M,Bordelon Y M,Ritz B. Statin use andthe risk Parkinson disease[ J]. Neurology ,2008 ,70( 16 Pt 2);1418 -1422.
6Santana AN,Kairalla RA,Carvalho CR. Potential role of statin use in idiopathic pulmonary fibrosis.Am J Respir Crit Care Med. 2008 May 1;177 (9):1048.
7Kogan EA, Tyong FV,Demura SA [The mechanism of lung tissue remodeling in the progression of idiopathic pulmonary fibrosis]. Arkh Patol. 2010, 72 (4):30-36.
8Wallaeh-Dayan SB,Golan-Gerstl R, Breuer R. Evasion of myofibmblasts from immune surveillance: a mechanism for tissue fibrosis. Proc Nad Acad Sci U S A. 2007, 104(51):20460-20465.
9Smith MR,Gangireddy SR,Narala VR, Hogaboam CM,Standiford TJ, Christensen PJ,Kondapi AK, Reddy RC.Curcumin inhibits fibrosis-related effects in IPF fibmblasts and in mice following bleomycin-induced lung injury.Am J Physiol Lung Cell Mol Physiol. 2010, 298(5):L616-625.
10Tan A,Levrey H,Dahm C, Polunovsky VA, Rubins .1, Bitterman PB. Lovastatin induces fibroblast apoptosis in vitro and in vivo.A possible therapy for fibroproliferative disorders.Am J Respir Crit Care Med. 1999,159 (1):220-227.
